本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LAVA Therapeutics N.V.

1.74
0.0000
成交量:- -
成交額:50.53萬
市值:4,577.12萬
市盈率:-2.02
高:1.74
開:1.74
低:1.74
收:1.74
52周最高:2.00
52周最低:0.8502
股本:2,630.53萬
流通股本:1,022.19萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.8620
每股收益(LYR):-0.9359
淨資產收益率:-101.51%
總資產收益率:-19.92%
市淨率:3.61
市盈率(LYR):-1.86

資料載入中...

2025/02/25

重要事件披露

Form 8-K - Current report
2025/01/02

重要事件披露

Form 8-K - Current report
2024/03/20

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/07

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/04/11

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/24

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/23

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/12/12

SEC問詢函

CORRESP [Cover] - Correspondence
2022/10/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/20

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/24

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals